Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Change in Account Payables (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Change in Account Payables over the past 9 years, most recently at -$1.5 million for Q4 2023.

  • For Q4 2023, Change in Account Payables fell 252.89% year-over-year to -$1.5 million; the TTM value through Dec 2023 reached $1.0 million, up 500.26%, while the annual FY2024 figure was $1.6 million, 55.93% up from the prior year.
  • Change in Account Payables for Q4 2023 was -$1.5 million at Corbus Pharmaceuticals Holdings, down from $3.2 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $5.2 million in Q4 2019 and troughed at -$3.9 million in Q4 2020.
  • A 5-year average of -$214380.5 and a median of -$824899.0 in 2020 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: surged 1984.95% in 2019 and later crashed 441.2% in 2022.
  • Year by year, Change in Account Payables stood at $5.2 million in 2019, then tumbled by 175.49% to -$3.9 million in 2020, then skyrocketed by 80.66% to -$759706.0 in 2021, then skyrocketed by 229.06% to $980459.0 in 2022, then plummeted by 252.89% to -$1.5 million in 2023.
  • Business Quant data shows Change in Account Payables for CRBP at -$1.5 million in Q4 2023, $3.2 million in Q3 2023, and $184056.0 in Q2 2023.